Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 7 715-720, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection

SC Murray, RS Sandler, TO Keku, CM Lyles, RC Millikan, SI Bangdiwala, LL Kupper, W Jiang and MH Ulshen
Department of Medicine, University of North Carolina at Chapel Hill 27599-7080, USA.

Rectal mucosal proliferation has been promoted as an intermediate marker for risk of colorectal neoplasia. Proliferating cell nuclear antigen (PCNA) immunohistochemistry has become a standard method to measure cell proliferation. Whole-crypt dissection may provide a technically simpler method for determining proliferation within an entire crypt. We conducted a study to assess the reliability (reproducibility) of whole-crypt dissection in 10 subjects. Reliability of whole-crypt dissection with the subject as the unit of observation was excellent. The intraclass correlation coefficient for subjects was 0.93. Biopsy-to-biopsy reliability was lower (r=0.86) and crypt-to-crypt reliability lower still (r = 0.35). There was poor correlation between measures of proliferation index using the two techniques (Kendall's tau = 0.13; P = 0.08). Compartment analysis based on the percentage of the total number of labeled cells appearing in each crypt quartile also did not demonstrate a significant correlation between the two measures. We conclude that PCNA labeling index and whole-crypt mitotic count are not comparable measures of rectal mucosal proliferation.

This article has been cited by other articles:

				R. S. Sandler, M. S. Cummings, T. O. Keku, A. Terse, and N. Mehta Disposable versus Reusable Biopsy Forceps for Colorectal Epithelial Cell Proliferation in Humans Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1123 - 1125. [Abstract] [Full Text]

				R. S. Sandler, J. A. Baron, T. D. Tosteson, J. S. Mandel, and R. W. Haile Rectal Mucosal Proliferation and Risk of Colorectal Adenomas: Results from a Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 653 - 656. [Abstract] [Full Text]